Course Listing
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Browse All MDS Courses
New courses are added regularly. If there are not courses listed in the category you are searching, more will be scheduled at a later date. Check back soon or sign up for email notifications.
Please wait while we gather your results.
Journal CME 40.05: Artificial Intelligence-Based Virtual Assistant for the Diagnostic Approach of Chronic Ataxias
On Demand
Journal CME
60 Minutes
Foundational / Beginner
CME Credits:1.00992 <p>The Journal CME 40.05 article aims to develop and validate an AI powered virtual assistant for diagnosing chronic ataxias.</p> Lucas Alessandro, MD 60 1.00 2025-05-21 https://education.movementdisorders.org/Detail/992/Journal-CME-40-05:-Artificial-Intelligence-Based-Virtual-Assistant-for-the-Diagnostic-Approach-of-Chronic-Ataxias https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-05-21T00:00:00 2026-05-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.05%20-%20Disclosures_20052025015905.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong><br>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.<br><br><strong>LEARNING OBJECTIVES</strong><br>Upon completion of this activity, learners will be able to:<br>1. Understand the diagnostic challenges associated with chronic ataxias due to their clinical and genetic heterogeneity<br>2. Assess how AI can improve diagnostic accuracy and efficiency for chronic ataxias<br>3. Evaluate the performance of the AI-based virtual assistant in diagnosing chronic ataxias<br><br><strong>INTENDED AUDIENCE</strong><br>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.<br><br><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong><br>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.<br>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).<br>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.<br>4. Adobe Flash Player 12.0 (or higher).<br>5. Adobe Reader to print certificate.<br><br><br></p> 0 /Courses/Journal-CME-40.05-Artificial-Intelligence-Based-Virtual-Assistant-for-the-Diagnostic-Approach-of-Chronic-Ataxias.htm Journal CME 40.05: Artificial Intelligence-Based Virtual Assistant for the Diagnostic Approach of Chronic Ataxias Journal CME 40.05 2025-05-27T18:00:56.423 0 0 Foundational / Beginner Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 40.04: Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson’s Disease
On Demand
Journal CME
60 Minutes
Foundational / Beginner, Experienced / Intermediate
CME Credits:1.00979 <p>The Journal CME 40.04 article aims to unravel the pathological relationship between human endogenous retrovirus K (HERV-K) and PD, determine the localization of HERV-K in the brain, determine whether HERV-K levels are altered in PD brain and blood, and examine whether HERV-K could serve as a biomarker for PD.</p> YuHong Fu, PhD 60 1.00 2025-05-05 https://education.movementdisorders.org/Detail/979/Journal-CME-40-04:-Human-Endogenous-Retrovirus-K-in-Astrocytes-Is-Altered-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-05-05T00:00:00 2026-05-05T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.04%20-%20Disclosures_02052025032439.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the potential pathological role of HERV-K in Parkinson’s disease (PD)</p><p>2. Identify the localization of HERV-K expression in the brain in relation to PD</p><p>3. Evaluate the potential of HERV-K as a biomarker through its expression levels in PD brain and blood</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.04-Human-Endogenous-Retrovirus-K-in-Astrocytes-Is-Altered-in-Parkinsons-Disease.htm Journal CME 40.04: Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson’s Disease Journal CME 40.04 2025-05-05T09:01:00.803 0 0 Foundational / Beginner Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 40.03: Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson’s Disease
On Demand
Journal CME
60 Minutes
Foundational / Beginner
CME Credits:1.00950 <p>The Journal CME 40.03 article provides a study to assess the diagnostic and prognostic capabilities of mtDNA-CN in PD.</p> Sungyang Jo, MD, PhD 60 1.00 2025-03-03 https://education.movementdisorders.org/Detail/950/Journal-CME-40-03:-Mitochondrial-DNA-Copy-Number-as-a-Potential-Biomarker-for-the-Severity-of-Motor-Symptoms-and-Prognosis-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-03-03T00:00:00 2026-03-03T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.03%20-%20Disclosures_21032025112928.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the importance of the necessity for accurate and cost-effective prognostic biomarkers</p><p>2. Assess the use of prognostic biomarkers as crucial for patient risk stratification, providing potential applicability in both clinical settings and research trials</p><p>3. Evaluate how blood mtDNA-CN may function as a diagnostic biomarker for PD and a prognostic marker for dementia in patients with PD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.03-Mitochondrial-DNA-Copy-Number-as-a-Potential-Biomarker-for-the-Severity-of-Motor-Symptoms-and-Prognosis-in-Parkinsons-Disease.htm Journal CME 40.03: Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson’s Disease Journal CME 40.03 2025-03-25T12:00:55.470 0 0 Foundational / Beginner Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 40.02: All-Cause and Cause-Specific Mortality in Tourette Syndrome and Chronic Tic Disorder
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00925 <p>The Journal CME 40.02 article provides a study to estimate the risk of all-cause and cause-specific mortality in individuals with Tourette syndrome/chronic tic disorder compared with unaffected matched individuals and unaffected full siblings.</p> Lorena Fernandez de la Cruz, PhD 60 1.00 2025-02-28 https://education.movementdisorders.org/Detail/925/Journal-CME-40-02:-All-Cause-and-Cause-Specific-Mortality-in-Tourette-Syndrome-and-Chronic-Tic-Disorder https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-02-28T00:00:00 2026-02-28T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal CME 40.02 - Disclosures_26022025095412.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Evaluate the risk of all-cause and cause-specific mortality of individuals with TS/CTD.</p><p>2. Understand the importance of exploring the specific natural causes leading to deaths in this patient group.</p><p>3. Assess the observations of the sibling comparison and relation to familial confounding.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate</p> 0 /Courses/Journal-CME-40.02-All-Cause-and-Cause-Specific-Mortality-in-Tourette-Syndrome-and-Chronic-Tic-Disorder.htm Journal CME 40.02: All-Cause and Cause-Specific Mortality in Tourette Syndrome and Chronic Tic Disorder Journal CME 40.02 2025-02-28T00:01:49.403 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 40.01: 18F-Florzolotau PET imaging unveils tau pathology in dementia with Lewy bodies
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00907 <p>The Journal CME 40.01 article provides a study on the topographical patterns of tau deposition in DLB and to investigate the in vivo pathological distinction between DLB and AD in virtue of the 18F-Florzolotau positron emission tomography (PET) imaging.</p> Gan Tang, MD 60 1.00 2025-01-21 https://education.movementdisorders.org/Detail/907/Journal-CME-40-01:-18F-Florzolotau-PET-imaging-unveils-tau-pathology-in-dementia-with-Lewy-bodies https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-01-21T00:00:00 2026-01-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2040.01%20-%20Disclosure%20_18122024025802.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the difficulties in accurate diagnosis of dementia with Lewy bodies (DLB).</p><p>2. Assess how 18F-Florzolotau PET imaging confirmed significant tau deposition in widespread cortical areas in DLB patients.</p><p>3. Evaluate how the study’s diverse tau profiles provide insights into differentiating DLB from Alzheimer’s disease in vivo.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate</p> 0 /Courses/Journal-CME-40.01-18F-Florzolotau-PET-imaging-unveils-tau-pathology-in-dementia-with-Lewy-bodies.htm Journal CME 40.01: 18F-Florzolotau PET imaging unveils tau pathology in dementia with Lewy bodies Journal CME 40.01 2025-01-21T03:00:52.533 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 39.12: Immunometabolic signature and tauopathy markers in blood cells of Progressive Supranuclear Palsy
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00906 <p>The Journal CME 39.12 article provides a summary to a broad biological characterization of peripheral immune cells in a selected PSP cohort.</p> Marco Rosina, MS, PhD 60 1.00 2024-12-21 https://education.movementdisorders.org/Detail/906/Journal-CME-39-12:-Immunometabolic-signature-and-tauopathy-markers-in-blood-cells-of-Progressive-Supranuclear-Palsy https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2024-12-21T00:00:00 2025-12-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.12%20-%20Disclosure_18122024022801.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the biological features of peripheral immune cells in PSP patients.</p><p>2. Assess the link between peripheral immunity and central neuropathology and the relative translational reliability of PBMCs in PSP.</p><p>3. Evaluate how this study widened the landscape of potential disease-modifying treatments for PSP.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-39.12-Immunometabolic-signature-and-tauopathy-markers-in-blood-cells-of-Progressive-Supranuclear-Palsy.htm Journal CME 39.12: Immunometabolic signature and tauopathy markers in blood cells of Progressive Supranuclear Palsy Journal CME 39.12 2024-12-21T00:02:24.240 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 39.11: Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00901 The Journal CME 39.11 article provides an investigation on skin tau quantification as a potential biomarker for Huntington's disease and its correlation with disease burden outcomes. Iñigo Ruiz-Barrio, MD 60 1.00 2024-11-21 https://education.movementdisorders.org/Detail/901/Journal-CME-39-11:-Skin-Tau-Quantification-as-a-Novel-Biomarker-in-Huntington's-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2024-11-21T00:00:00 2025-11-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.11%20%E2%80%93%20Disclosures_08112024014850.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand how skin tau quantification could serve as a potential biomarker for the pathophysiology of Huntington’s disease </p><p>2. Assess how using skin tau levels in cluster analysis along with genetic and clinical measures could lead to improved subject stratification</p><p>3. Evaluate how tau levels could capture significant changes during disease progression</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-39.11-Skin-Tau-Quantification-as-a-Novel-Biomarker-in-Huntingtons-Disease.htm Journal CME 39.11: Skin Tau Quantification as a Novel Biomarker in Huntington's Disease Journal CME 39.11 2024-11-21T00:01:13.447 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 39.10: Frequency-Selective Suppression of Essential Tremor via Transcutaneous Spinal Cord Stimulation
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00894 The Journal CME 39.10 article provides an investigation of the potential of tSCS to disrupt tremor in a frequency-dependent manner in a cohort of patients with ET. Alejandro Pascual-Valdunciel, PhD 60 1.00 2024-10-21 https://education.movementdisorders.org/Detail/894/Journal-CME-39-10:-Frequency-Selective-Suppression-of-Essential-Tremor-via-Transcutaneous-Spinal-Cord-Stimulation https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2024-10-21T00:00:00 2025-10-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.10%20-%20Disclosures_09102024032910.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand the difficulties surrounding the general understanding of essential tremor and the ability to treat the syndrome</p><p>2. Assess the ways in which the study explored the potential of transcutaneous spinal cord electrical stimulation (tSCS) to modify the propagation of tremor to the muscles in ET syndrome</p><p>3. Evaluate how the study demonstrated that open-loop cervical tSCS effectively reduced postural tremor in ET when delivered at the subject’s tremor frequency</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-39.10-Frequency-Selective-Suppression-of-Essential-Tremor-via-Transcutaneous-Spinal-Cord-Stimulation.htm Journal CME 39.10: Frequency-Selective Suppression of Essential Tremor via Transcutaneous Spinal Cord Stimulation Journal CME 39.10 2024-11-08T15:00:51.040 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 39.09: An online mindfulness-based group intervention for tics: A pilot randomized controlled trial
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00878 <p>The Journal CME 39.09 article provides a study comparing a novel, video conference delivered group mindfulness-based intervention for tics (MBIT) to videoconference-delivered group psychoeducation, relaxation, and supportive therapy (PRST) for adults with TS or PTD.</p> Hannah E. Reese, PhD 60 1.00 2024-08-21 https://education.movementdisorders.org/Detail/878/Journal-CME-39-09:-An-online-mindfulness-based-group-intervention-for-tics:-A-pilot-randomized-controlled-trial https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2024-08-21T00:00:00 2025-08-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%2039.09%20%E2%80%93%20Disclosures_20082024033339.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand the importance of developing and testing effective, accessible, and safe treatment options for individuals with tics.</p><p>2. Assess how mindfulness-based interventions can be beneficial for a wide range of clinical concerns.</p><p>3. Evaluate the limitations of this study and how the results may be affected.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-39.09-An-online-mindfulness-based-group-intervention-for-tics-A-pilot-randomized-controlled-trial.htm Journal CME 39.09: An online mindfulness-based group intervention for tics: A pilot randomized controlled trial Journal CME 39.09 2024-08-21T12:00:45.283 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA
Journal CME 39.08: Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.00877 <p>The Journal CME 39.08 article provides a summary to the need to evaluate how cerebrovascular activity is altered in Lewy body diseases. In addition, the article focuses on the several avenues for future research that may lead to treatments early in the disease course, prior to neurodegeneration. </p> Sephira G. Ryman, PhD 60 1.00 2024-08-21 https://education.movementdisorders.org/Detail/877/Journal-CME-39-08:-Abnormal-Cerebrovascular-Activity,-Perfusion,-and-Glymphatic-Clearance-in-Lewy-Body-Diseases https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2024-08-21T00:00:00 2025-08-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Journal%20CME%20%2039.08%20-%20Disclosures%20_20082024025449.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Evaluate the future directions and opportunities for early intervention highlighted by this review.</p><p>2. Assess the treatment approaches this review directly informs, that can be used early in the disease course, prior to neurodegeneration.</p><p>3. Understand the proposed model by which altered cerebrovascular activity may lead to hypoperfusion and reduced clearance of interstitial waste/<br><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><strong><br></strong></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-39.08-Abnormal-Cerebrovascular-Activity-Perfusion-and-Glymphatic-Clearance-in-Lewy-Body-Diseases.htm Journal CME 39.08: Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases Journal CME 39.08 2024-08-21T12:00:43.143 0 0 Experienced / Intermediate Clinician Industry Researcher Resident Student Journal CME CME On-Demand English USA